Results 251 to 260 of about 9,561,546 (382)

Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse.

, 1989
Roberto Cantello, Marco Aguggia, M Gilli, M Delsedime, I Chiardo Cutin, A. Riccio, Roberto Mutani   +6 more
openalex   +1 more source

Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory. [PDF]

, 1988
Bonnie Levin, María M. Llabre, William J. Weiner   +2 more
openalex   +1 more source

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

Movement Disorders, 2008
M. Hely, W. Reid, M. Adena, G. Halliday, J. Morris   +4 more
semanticscholar   +1 more source

Decoding Dental Stem Cell Aging: Mechanisms, Therapeutic Strategies, and Beyond

Advanced Science, EarlyView.
Dental stem cell (DSC) aging involves genomic instability, mitochondrial dysfunction, telomere attrition, and epigenetic alterations, leading to impaired proliferation, reduced differentiation potential, and pro‐inflammatory secretory activity. These processes drive cellular senescence and compromise regenerative and immunomodulatory functions, thereby
Xinyuan Zhao, Yunfan Lin, Pei Lin, Ye Lu, Jiarong Zheng, Xu Chen, Zihao Zhou, Li Cui   +7 more
wiley   +1 more source

Dispositional and situational empathy in Parkinson's disease and their relationship with cognition. [PDF]

Front Psychol
Alonso-Recio L, Mendoza L, Pérez Á, Rubio S, Serrano JM.   +4 more
europepmc   +1 more source

Clinical and pharmacological problems of deprenyl (selegiline) treatment in Parkinson's disease

, 1983
G M Stern, Andrew J. Lees, R Hardie, M. Sandler   +3 more
openalex   +1 more source

Dementia and cognitive impairment in Parkinson's disease. [PDF]

, 1988
F. Girotti, Paola Soliveri, F. Carella, I. Piccolo, Paolo Caffarra, Massimo Musicco, T. Caraceni   +6 more
openalex   +1 more source

Parkinson's Disease

Neurobiology of Disease, 2000
openaire   +3 more sources

Microglial Deletion of Hrh4 Alleviates Alzheimer's Disease Pathologies by Enhancing Microglial Phagocytosis of Amyloid‐β and Tau

Advanced Science, EarlyView.
Histamine H4 receptor (H4R) antagonist VUF6002 mimics low‐dose X‐ray irradiation in aged Alzheimer's disease (AD) mice, enhancing microglial clearance of amyloid‐beta/hyperphosphorylated tau aggregates and restoring cognition. Microglial H4R deletion activates cAMP/TGF‐β1/Smad3 pathway, enhancing phagocytosis, while TGF‐β receptor 1 deletion abolishes ...
Yi‐Jun Xu, Tan Wu, Larry Tso‐Lun Lo, Chi‐Chiu Ko, Xin Wang, Chi Him Eddie Ma   +5 more
wiley   +1 more source

New horizons for Parkinson's disease treatment? [PDF]

Lancet Reg Health Am
The Lancet Regional Health-Americas.
europepmc   +1 more source